High expression of PD-L1 is associated with poor-prognosis characterized by progesterone receptor (PR)-negative, estrogen receptor (ER)-negative, and human epidermal growth factor receptor 2 (HER2)-positive status, large tumor size, and high proliferation and grade [13–15]. This evidence concerns the gene ESR1 and neoplasm.